Member of the 1000 Post Club kellysue Posted September 14, 2005 Member of the 1000 Post Club Report Share Posted September 14, 2005 Hi guys, Came across this and thought I'd post it. Kelly Mifepristone Orphan Drug Status for Cushing's Syndrome Secondary to ACTH Secretion in EU On July 27, the European Commission approved orphan drug status for mifepristone (made by Laboratoire HRA Pharma, France) in the treatment of Cushing's syndrome secondary to ectopic adrenocorticotrophic hormone (ACTH) secretion. The condition affects fewer than 5,000 individuals in the European Union (EU). The product acts as a reversible competitive antagonist at cortisol receptors, thereby decreasing the effects of elevated cortisol levels and improving long-term outcome. Mifepristone (made by HRA Pharma) was approved for this orphan drug indication by the U.S. Food and Drug Administration (FDA) in February 2005. Mifepristone was also granted traditional approval by the FDA in September 2000 for the medical termination of intrauterine pregnancies. http://www.medscape.com/viewarticle/512621 Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.